Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury

Noninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypoth...

Full description

Bibliographic Details
Main Authors: Shalini Das Gupta, Robert Ciszek, Mette Heiskanen, Niina Lapinlampi, Janne Kukkonen, Ville Leinonen, Noora Puhakka, Asla Pitkänen
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/4/1563
_version_ 1797415075102851072
author Shalini Das Gupta
Robert Ciszek
Mette Heiskanen
Niina Lapinlampi
Janne Kukkonen
Ville Leinonen
Noora Puhakka
Asla Pitkänen
author_facet Shalini Das Gupta
Robert Ciszek
Mette Heiskanen
Niina Lapinlampi
Janne Kukkonen
Ville Leinonen
Noora Puhakka
Asla Pitkänen
author_sort Shalini Das Gupta
collection DOAJ
description Noninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypothesized that acutely altered plasma miRNAs could serve as diagnostic biomarkers both in the lateral fluid percussion injury (FPI) model and clinical mTBI. We performed plasma small RNA-sequencing from adult male Sprague–Dawley rats (<i>n</i> = 31) at 2 days post-TBI, followed by polymerase chain reaction (PCR)-based validation of selected candidates. miR-9a-3p, miR-136-3p, and miR-434-3p were identified as the most promising candidates at 2 days after lateral FPI. Digital droplet PCR (ddPCR) revealed 4.2-, 2.8-, and 4.6-fold elevations in miR-9a-3p, miR-136-3p, and miR-434-3p levels (<i>p</i> < 0.01 for all), respectively, distinguishing rats with mTBI from naïve rats with 100% sensitivity and specificity. DdPCR further identified a subpopulation of mTBI patients with plasma miR-9-3p (<i>n</i> = 7/15) and miR-136-3p (<i>n</i> = 5/15) levels higher than one standard deviation above the control mean at <2 days postinjury. In sTBI patients, plasma miR-9-3p levels were 6.5- and 9.2-fold in comparison to the mTBI and control groups, respectively. Thus, plasma miR-9-3p and miR-136-3p were identified as promising biomarker candidates for mTBI requiring further evaluation in a larger patient population.
first_indexed 2024-03-09T05:42:48Z
format Article
id doaj.art-0a5b373e9b214357bb68bccfffb13c93
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T05:42:48Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0a5b373e9b214357bb68bccfffb13c932023-12-03T12:23:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-02-01224156310.3390/ijms22041563Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain InjuryShalini Das Gupta0Robert Ciszek1Mette Heiskanen2Niina Lapinlampi3Janne Kukkonen4Ville Leinonen5Noora Puhakka6Asla Pitkänen7A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandDepartment of Neurosurgery, Kuopio University Hospital, 70029 Kuopio, FinlandDepartment of Neurosurgery, Kuopio University Hospital, 70029 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, FinlandNoninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypothesized that acutely altered plasma miRNAs could serve as diagnostic biomarkers both in the lateral fluid percussion injury (FPI) model and clinical mTBI. We performed plasma small RNA-sequencing from adult male Sprague–Dawley rats (<i>n</i> = 31) at 2 days post-TBI, followed by polymerase chain reaction (PCR)-based validation of selected candidates. miR-9a-3p, miR-136-3p, and miR-434-3p were identified as the most promising candidates at 2 days after lateral FPI. Digital droplet PCR (ddPCR) revealed 4.2-, 2.8-, and 4.6-fold elevations in miR-9a-3p, miR-136-3p, and miR-434-3p levels (<i>p</i> < 0.01 for all), respectively, distinguishing rats with mTBI from naïve rats with 100% sensitivity and specificity. DdPCR further identified a subpopulation of mTBI patients with plasma miR-9-3p (<i>n</i> = 7/15) and miR-136-3p (<i>n</i> = 5/15) levels higher than one standard deviation above the control mean at <2 days postinjury. In sTBI patients, plasma miR-9-3p levels were 6.5- and 9.2-fold in comparison to the mTBI and control groups, respectively. Thus, plasma miR-9-3p and miR-136-3p were identified as promising biomarker candidates for mTBI requiring further evaluation in a larger patient population.https://www.mdpi.com/1422-0067/22/4/1563biomarkermicroRNAmild TBImiR-9-3pmiR-136-3pplasma
spellingShingle Shalini Das Gupta
Robert Ciszek
Mette Heiskanen
Niina Lapinlampi
Janne Kukkonen
Ville Leinonen
Noora Puhakka
Asla Pitkänen
Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
International Journal of Molecular Sciences
biomarker
microRNA
mild TBI
miR-9-3p
miR-136-3p
plasma
title Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
title_full Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
title_fullStr Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
title_full_unstemmed Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
title_short Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
title_sort plasma mir 9 3p and mir 136 3p as potential novel diagnostic biomarkers for experimental and human mild traumatic brain injury
topic biomarker
microRNA
mild TBI
miR-9-3p
miR-136-3p
plasma
url https://www.mdpi.com/1422-0067/22/4/1563
work_keys_str_mv AT shalinidasgupta plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT robertciszek plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT metteheiskanen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT niinalapinlampi plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT jannekukkonen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT villeleinonen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT noorapuhakka plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury
AT aslapitkanen plasmamir93pandmir1363paspotentialnoveldiagnosticbiomarkersforexperimentalandhumanmildtraumaticbraininjury